CLINICAL_TRIALS ClinicalTrials.gov record update

Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02748798
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:07.915212+00:00
Published At: 2024-10-15T00:00:00+00:00
Record Updated At: 2024-10-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lung Transplant", "Lung Resection", "Lung Cancer", "Asthma", "Cystic Fibrosis", "Chronic Obstructive Pulmonary Disease", "Emphysema", "Mesothelioma", "Asbestosis", "Pulmonary Embolism", "Interstitial Lung Disease", "Pulmonary Fibrosis", "Bronchiectasis", "Seasonal Allergies", "Cold Virus", "Lung Infection", "Pulmonary Hypertension", "Pulmonary Dysplasia", "Obstructive Sleep Apnea"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-10-15"
protocolSection.identificationModule.nctId: "NCT02748798"
protocolSection.identificationModule.officialTitle: "Developing Optimal Parameters for Hyperpolarized Noble Gas (3He and 129Xe) and Inert Fluorinated Gas Magnetic Resonance Imaging of Lung Disorders"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.